The Seer spinoff recently closed a $46 million funding round that it is using to support efforts in nucleic acid, proteomic, and metabolomic biomarker discovery.
Read the full article in GenomeWeb here.
November 7, 2024
​Prognomiq raises $34M for early lung cancer detection test
November 5, 2024
PrognomiQ raises $34M for lung cancer test
May 16, 2024
As Multiomics Progresses, Data Challenges Come to the Fore
